If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
455.00    18.00 (4.12%)
Bid:
453.00
Ask:
459.00
Spread: 6.00 (1.325%)
Market Cap: £223.78m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Re Agreement

21 Mar 2006 14:37

Zotefoams PLC21 March 2006 21 March 2006 Commercial agreement between Zotefoams plc ("Zotefoams") and Sekisui ChemicalCompany Limited and its subsidiaries ("Sekisui Group") With immediate effect, Zotefoams and Sekisui Group have agreed to terminatetheir commercial agency relationships in Europe and North America. Sekisui willcontinue to act as distributor for Zotefoams' products in Asia until 30 April2006. During 2000 and 2001 Zotefoams entered into a number of worldwide sales andmarketing alliances for polyolefin foams with Sekisui Group, who act asexclusive agent and distributor for Zotefoams in Continental Europe (throughtheir European subsidiary, Alveo AG ("Alveo")) and Asia respectively. SekisuiGroup also act as an agent for certain of Zotefoams' customers in North Americathrough its American subsidiary, Voltek LLC. On 15 December 2005 and on 14 March 2006, Zotefoams announced that it had, forsome time, been in negotiations with Sekisui Group in relation to certain of itsobligations under two of these agreements. Zotefoams announced that while it wasstill open to a resolution by other means, it had instigated arbitrationproceedings. Termination of these arrangements was agreed subject to Zotefoams plc payingAlveo a reduced termination fee of euro 1.4 million as well as dropping alldisputes due to be heard in arbitration. Zotefoams will assume directresponsibility for all customer matters in all regions with plans to increasedirect sales resource to support this, although it is envisaged separateagreements may be appropriate in Asia in the medium term. In 2005, Zotefoams paid Sekisui Group approximately euro 1.5 million in agent'scommissions (principally to Alveo) under these arrangements. From 20 March 2006,no further commissions will be earned by Sekisui Group. Zotefoams is pleased that these disputes have been resolved with Sekisui andlooks forward to working directly with its customers. Enquiries: Zotefoams plc 0208-664-1600David Stirling, Managing DirectorClifford Hurst, Finance Director Financial Dynamics Limited 0774-602-739 / 0207-831-3113Sarah MacLeod / Deborah Scott This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Apr 20212:06 pmRNSDirector/PDMR Shareholding
12th Apr 20214:09 pmRNSDirector/PDMR Shareholding
25th Mar 20211:26 pmRNSDirector/PDMR Shareholding
23rd Mar 20213:19 pmRNSCorrection: Preliminary Results
23rd Mar 20217:00 amRNSPreliminary Results
12th Mar 20212:53 pmRNSDirector/PDMR Shareholding
10th Mar 20211:12 pmRNSHolding(s) in Company
9th Mar 20213:13 pmRNSHolding(s) in Company
9th Mar 20213:05 pmRNSHolding(s) in Company
9th Mar 20211:55 pmRNSHolding(s) in Company
8th Mar 20213:04 pmRNSResult of secondary placing in Zotefoams plc
8th Mar 202112:00 pmRNSProposed secondary placing in Zotefoams plc
8th Mar 20217:00 amRNSNotice of results and investors presentation
5th Mar 20214:36 pmRNSPrice Monitoring Extension
23rd Feb 20217:00 amRNSProduction starts at new £23m plant in Poland
15th Feb 20217:00 amRNSPolish factory virtual tour and investor Q&A
12th Feb 20214:20 pmRNSDirector/PDMR Shareholding - Replacement
12th Feb 20213:54 pmRNSDirector/PDMR Shareholding
12th Feb 20213:38 pmRNSDirector/PDMR Shareholding
8th Feb 20214:41 pmRNSSecond Price Monitoring Extn
8th Feb 20214:35 pmRNSPrice Monitoring Extension
21st Jan 20217:00 amRNSOperational and Trading Update
12th Jan 20213:50 pmRNSDirector/PDMR Shareholding
14th Dec 20204:19 pmRNSDirector/PDMR Shareholding
12th Nov 20203:40 pmRNSDirector/PDMR Shareholding
5th Nov 20207:00 amRNSOperational and Trading Update
22nd Oct 202010:36 amRNSDirector/PDMR Shareholding
14th Oct 20207:00 amRNSDirector/PDMR Shareholding
9th Oct 20207:00 amRNSDirector/PDMR Shareholding
7th Oct 20207:00 amRNSExternal Auditor Appointment
1st Oct 20204:13 pmRNSDirector/PDMR Shareholding
16th Sep 20204:29 pmRNSDirector/PDMR Shareholding
11th Sep 20204:41 pmRNSSecond Price Monitoring Extn
11th Sep 20204:35 pmRNSPrice Monitoring Extension
9th Sep 20205:51 pmRNSHolding(s) in Company
1st Sep 20204:40 pmRNSSecond Price Monitoring Extn
1st Sep 20204:35 pmRNSPrice Monitoring Extension
18th Aug 202010:54 amRNSDirector/PDMR Shareholding
12th Aug 20203:52 pmRNSDirector/PDMR Shareholding
11th Aug 20207:00 amRNSInterim Results
14th Jul 20207:00 amRNSDirector/PDMR Shareholding
9th Jul 20204:35 pmRNSPrice Monitoring Extension
9th Jul 20207:00 amRNSNotice of Results
16th Jun 20205:05 pmRNSHolding(s) in Company
12th Jun 20203:25 pmRNSDirector/PDMR Shareholding
8th Jun 20202:06 pmRNSResult of the 2020 Annual General Meeting
2nd Jun 20208:00 amRNSOperational and Trading Update
22nd May 202012:07 pmRNSSecond Price Monitoring Extn
22nd May 202012:02 pmRNSPrice Monitoring Extension
14th May 20203:48 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.